πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11311532

High dosage valbenazine formulation and compositions, methods, and kits related thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11026939

High dosage valbenazine formulation and compositions, methods, and kits related thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10851103

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10851104

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10844058

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10065952

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted